Innovations in medical publishing
Featuring the ‘No deal, no review’ campaign to break down paywalls, research on how best to generate and communicate science, and ‘Tinder for preprints’ Finnish
Featuring Synlett’s foray into ‘intelligent crowd’ peer review, outrage from researchers over research posting restrictions, and the ICMJE’s latest guidelines on data sharing
An invitation to share your thoughts on ORCID, ways to support preprints and a look at how piracy can negatively affect open-access journals
Including next steps for Open Pharma, the launch of the MyScienceOpen platform, an update on Horizon 2020 and a spotlight on predatory publishing Open Pharma
Since the sudden disappearance of his list of so-called predatory journals in January 2017, Jeffrey Beall has maintained silence on the subject for which he
The first Open Pharma workstream meetings took place last week. The collated key insights and next steps can be found below. If you would like to